Repligen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.

CEO

Olivier Dominique Loeillot

CEOOlivier Dominique Loeillot

Employees

1,778

Employees1,778

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

1981

Founded1981

Employees

1,778

Employees1,778

RGEN Key Statistics

Market cap

8.37B

Market cap8.37B

Price-Earnings ratio

-603.96

Price-Earnings ratio-603.96

Dividend yield

—

Dividend yield—

Average volume

1.01M

Average volume1.01M

High today

$153.02

High today$153.02

Low today

$147.88

Low today$147.88

Open price

$150.81

Open price$150.81

Volume

1.26M

Volume1.26M

52 Week high

$182.52

52 Week high$182.52

52 Week low

$102.97

52 Week low$102.97

RGEN News

Simply Wall St 5d

Why Investors Shouldn't Be Surprised By Repligen Corporation's 28% Share Price Surge

Repligen Corporation ( ) shares have had a really impressive month, gaining 28% after a shaky period beforehand. Notwithstanding the latest gain, the annual sha...

Analyst ratings

83%

of 24 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.